Active, Not Recruiting
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992
- Conditions
- Adenocarcinoma, Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Bronchial Neoplasms, +13 more
- Locations
-
- City of Hope Cancer Center Duarte, California, United States
- California Cancer Associates for Research & Excellence, Inc. Encinitas, California, United States
- St. Joseph Hospital Orange, California, United States
- Torrance Health Association Redondo Beach, California, United States